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Summary 
Thrombospondins are a family of extracellular matrix 
proteins expressed throughout the developing ner- 
vous system that promote neurite outgrowth in vitro 
and help mediate the migration of granule cells across 
the molecular layer in explants of neonatal cerebellum. 
The receptors mediating these Interactions have not 
previously been Identified. In this study, monoclonal 
antibodies raised to the integHn (][31~1 heterodlmer are 
shown to inhibit neurite outgrowth by rat sympathetic 
neurons on thrombospondln-1.0~1~1 is found to be ex- 
pressed on the cell body, neurltes, and growth cones 
of sympathetic neurons in vitro and on sympathetic 
axons passing through the thrombospondin-rich outer 
sheath of the superior cervical ganglion in vivo, con- 
sistent with its role in mediating axon outgrowth. A 
receptor-Iigand binding assay is used to demonstrate 
the direct binding of Immunopurified 0~1 to thrombo- 
spondin-1. These results demonstrate a direct Interec- 
tion between the integrin (131~1 and thrombospondln-1, 
which mediates neurite outgrowth in vitro and is likely 
to mediate the same Interactions in vivo. 
Introduction 
During neuronal development, axons extend through a 
complex extracellular environment composed of a variety 
of adhesive substrates that promote axon outgrowth. 
Among these are extracellular matrix (ECM) components, 
such as laminin, collagen, fibronectin, vitronectin, tenas- 
cin, and thrombospondin (TSP) (reviewed in Reichardt and 
Tomaselli, 1991). These ECM components promote at- 
tachment and process outgrowth of several different neu- 
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ronal cell types in vitro and in many cases are expressed 
in appropriate spatiotemporal patterns during develop- 
ment to promote and guide axonal outgrowth in vivo. 
Although TSP in the adult is mainly found in platelets, 
polyclonal antibodies to platelet TSP stain the developing 
nervous system of the mouse at times of axon outgrowth 
and cell migration, disappearing after such processes are 
complete (O'Shea and Dixit, 1988). It is now apparent hat 
there are several TSP isoforms (TSP1-TSP4; Bornstein 
et al., 1991; Vos et al., 1992; Lawler et al., 1993) and 
TSP-like proteins, such as F-spondin and cartilage oligo- 
meric protein (Klar et al., 1992; Oldberg et al., 1992) en- 
coded by distinct genes, which demonstrate a high degree 
of sequence homology with platelet TSP (TSP1). Because 
of antibody cross-reactivity between the TSPs, the expres- 
sion patterns of these TSP isoforms have been best stud- 
ied by in situ hybridization. Iruela-Arispe et al. (1993) have 
shown that TSP1, TSP2, and TSP3 are all expressed in 
the developing murine embryonic nervous system, with 
TSP1 being expressed earliest, followed by TSP2 and later 
by TSP3. Expression of all three isoforms decreases sig- 
nificantly after birth. The expression pattern of TSP4 is not 
well characterized (Lawler et al., 1993). Their expression 
patterns suggest that TSP isoforms may play a role in 
cell migration and axon outgrowth during embryogenesis. 
Consistent with its widespread distribution, many distinct 
types of neurons, including sensory, sympathetic, spinal 
cord, and retinal neurons, extend processes on TSP1 in 
vitro (O'Shea et al., 1991; Osterhout et al., 1992; Neuge- 
bauer et al., 1991). In addition, anti-TSP antibodies inhibit 
migration of cerebellar granule cells in explants of neona- 
tal cerebellum (O'Shea et al., 1990). 
TSP was originally identified as a major component of 
platelet ~ granules that, upon release, functions in platelet 
aggregation (for review, see Frazier, 1991; Bornstein, 
1992). TSP1, the TSP isoform expressed by platelets, is 
a homotrimeric multidomain glycoprotein with each mono- 
mer containing an amino-terminal heparin-binding do- 
main, followed by a procollagen-like region, three proper- 
din-like repeats (TSP type 1 repeats), three epidermal 
growth factor-like repeats (TSP type 2 repeats), seven 
Ca2+-binding repeats (TSP type 3 repeats), and a carboxy- 
terminal cell attachment domain. TSP2 shares this same 
structural layout, whereas TSP3 and TSP4 lack the procol- 
lagen domain and the TSP type 1 repeats and have four 
TSP type 2 repeats. Cell attachment sites for a variety of 
nonneuronal cells have been localized to many of these 
domains in TSP1 (Frazier, 1991; Prater et al., 1991). In 
particular, neurite outgrowth from rat sympathetic neurons 
on TSP1 has been shown to be inhibited by an antibody 
recognizing the type 1 repeats of TSP1 (Osterhout et al., 
1992). Attachment of retinal neurons to TSP1, but not neu- 
rite outgrowth, is inhibited by heparin, implicating the hep- 
arin-binding domain as a neuronal cell attachment site 
(Neugebauer et al., 1991). Thus, neurons, like other cell 
types, appear to interact with more than one domain of TSP1. 
Neuron 
334 
For many neurons, recognition of ECM components is 
due in large part to integrins (reviewed in Reichardt and 
Tomaselli, 1991). Integrins are heterodimers composed 
of noncovalently associated a and I~ subunits. Integrins 
containing the I~1 subunit, which can associate with at least 
ten distinct a subunits, are particularly important for neu- 
ronal interactions with many ECM substrates (Reichardt 
and Tomaselli, 1991). Previous work has implicated a ~ 
integrin as a TSP1 receptor on retinal neurons that medi- 
ates neurite outgrowth (Neugebauer et al., 1991). Integrins 
proposed to be TSP1 receptors include czvl~3 in endothelial 
cells (Lawler et al., 1988), m,bl~a on melanoma cells (Tus- 
zynski et al., 1989), and a41~ and as~ in activated T cells 
(Yabkowitz et al., 1993). In this paper, we identify the inte- 
grin aal~ heterodimer as a neuronal TSP1 receptor, recog- 
nizing the type I repeats, that mediates neurite outgrowth 
of rat sympathetic neurons on purified TSP1 in vitro. This 
receptor is shown to be appropriately expressed to medi- 
ate such an interaction in vivo. 
Results 
Sympathetic Neurite Outgrowth on TSP1 
Rat neonatal sympathetic neurons from the superior cervi- 
cal ganglia (SCGs) were grown in serum-free medium for 
18-24 hr on plastic coated with TSP1. In agreement with 
earlier work (Osterhout et al., 1992), sympathetic neurons 
extended neurites on TSP1 in a dose-dependent manner, 
requiring a coating concentration of 6-12 pg/ml to support 
outgrowth (Figure 1A). QuantitaUon of outgrowth either in 
terms of percentage of neurons with neurites or number 
of neurites per unit area showed a similarly steep dose 
dependence on TSP1 concentration, with about 90% of 
the cells extending processes at a coating concentration 
of 50 pg/ml. The effects of function-blocking reagents on 
sympathetic neuron process outgrowth on TSP1 were de- 
termined using coating concentrations of 10-20 pg/ml, 
and outgrowth was quantitated in terms of number of neu- 
rites per unit area. Outgrowth on purified TSP1 was inhib- 
ited by an antibody to TSP1 (Figure 1B), demonstrating 
the substrate specificity. 
Sympathetic Neurite Outgrowth on TSP1 Is 
Inhibited by Anti-I~ Integrln Antibodies 
Experiments by Neugebauer et al. (1991) indicate that a 
l~-class integrin is involved in neurite outgrowth of chick 
retinal neurons on TSP1. To investigate the possible role 
of 13~-class integrins in mediating neurite outgrowth of rat 
sympathetic neurons on TSP1, the effect on outgrowth of 
a function-blocking monoclonal antibody (MAt)) was exam- 
ined. This antibody has previously been shown to inhibit 
glomerular epithelial cell attachment to laminin and colla- 
gen (Mendrick and Kelly, 1993). As shown in Figure 1B, 
this anti-I~ MAb inhibited neurite outgrowth on TSP1 to 
27% ± 7.6% of normal. The antibody almost completely 
inhibited neurite outgrowth on collagen IV (Col IV) and 
significantly reduced outgrowth on laminin-1 (LN-1), as 
has been described previously with a polyclonal anti-I~l 
antibody (Lein et al., 1991). Outgrowth on the recombinant 
extrecellular domain of the homophilic, Ca2+-dependent 
cell-adhesion molecule N-cadhedn was, if anything, slightly 
increased by this antibody, demonstrating that the anti- 
body is not toxic and has no nonspecific effects on neurite 
outgrowth. 
Characterization of pl-Class Integrlns Expressed 
by Sympathetic Neurons 
To determine which integrins are potential TSP1 recep- 
tors, we used subunit-specific antibodies to identify the 
integrins present on these neurons. As shown in Figure 
2 (lane 1), anti-131 integrin antibody immunoprecipitates a 
13~ integrin band with a size of 112 kDa as analyzed by 
SDS-PAGE, along with four associated ~z subunit bands 
of 185, 135, 128, and 122 kDa. The pattern seen here with 
an anti-I~ cytoplasmic domain IgG is also seen with the 
function-blocking anti-~ MAb, Ha2/11 (data not shown). 
The 185 kDa band corresponds to the al subunit (data not 
shown). The 135 kDa band contains ae, as, and possibly 
other integrin subunits (data not shown). The 122 kDa 
subunit has not been identified. The 128 kDa band is im- 
munoprecipitated with a polyclonal antibody tothe integrin 
,z~ cytoplasmic domain (lane 2). These data show that 
ml~, ~za131, and additional ~-class integrins are expressed 
by sympathetic neurons. 
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Figure 1. Sympathetic Neurite Outgrowth on 
TSP1 
(A) Neurite outgrowth of sympathetic neurons 
in response to various coating concentrations 
of TSP1. Neurite outgrowth was quantitated 
after 18 hr in culture, both in terms of percent- 
age of neurons with neurites (squares) and 
number of neurites in a unit area (circles). Error 
bars represent the range of duplicate wells in 
this particular experiment. 
(B) Inhibition of sympathetic neurite outgrowth 
on purified substrates. Sympathetic neurons 
were grown on TSP1 (closed bars), laminin-1 
(LN-1; open bars), collagen IV (Col IV; gray 
bars), or N-cadherin (hatched bars) for 15-18 
hr in the presence of different MAbs. Antibodies tested were an anti-I~l antibody (Ha2/11), two function-blocking anti-az MAbs (Ralph 3-1 and Ralph 
3-2), a non-function-blocking anti-aa MAb (Ralph 3-3), an anti-a, MAb (3A3), and an anti-TSP MAb, A 4.1 (TSP), as well as a no-antibody control 
(N). Outgrowth was quantitated interms of neurites per unit area nd normalized to the amount of neurite outgrowth seen with no antibody. Results 
are the mean values from several experiments ± SEM; asterisk, statistically significant to p < .001. 
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Figure 2. ImmunoprecipitationoflntegrinsfromSympatheticNeurons 
and Characterization of Ralph 3-2 Antibody 
SCGs were dissociated, grown in culture on a LN-1 substrate, biotinyl- 
ated, and extracted for immunoprecipitation. Immunoprecipitations 
were done with an anti-~l cytoplasmic domain antibody (lanes 1, 7, 
and 11), an anti-~x~ cytoplasmic domain antibody (lanes 2, 4, 5, and 
10), and an anti-Q3 MAb, Ralph 3-2 (lanes 3, 6, 8, and 9). Lanes 1--3 
show immunoprecipitations directly from a SCG extract. Arrows indi- 
cate four a bands, including (xl, as, and two other a bands of unknown 
composition. Also indicated by arrow is the 131 subunit. The unbound 
extract from the ~z3A cytoplasmic domain immunoprecipitate in lane 2 
was depleted twice more with the anti-a~ cytoplasmic domain antibody 
(lanes 4 and 5), then immunoprecipitated with the anti-a3 MAb Ralph 
3-2 (lane 6) or the anti-~l cytoplasmic domain antibody (lane 7). The 
unbound extract from the Ralph 3-2 immunoprecipitate in lane 3 was 
depleted twice more with Ralph 3-2 (lanes 8 and 9), then immunopre- 
cipitated with anti-a~ cytoplasmic domain antibody (lane 10) and anti- 
~1 cytoplasmic domain antibody (lane 1 1). 
Identification of o~13~ as a TSP1 Receptor 
Preliminary evidence with an anti-a3 polyclonal antibody 
suggested that a31~1 might be a I~-class TSP1 receptor on 
sympathetic neurons, but the specificity of the antibody 
could not be adequately documented. Therefore, MAbs 
to the native integrin heterodimer, a31~, purified from RuGli 
cells, a rat glioblastoma cell line, were generated. The 
MAbs were screened for the ability to stain live RuGli cells 
and immunoprecipitate he a31~1 integrin heterodimer. Of 
those MAbs that fit these criteria, 2 were found to inhibit 
neurite outgrowth on TSP1. These 2 antibodies, Ralph 3-1 
(for rat alpha 3) and Ralph 3-2, immunoprecipitate 128 
and 112 kDa proteins. These proteins comigrate with the 
a3 and ~ integrin subunits immunoprecipitated by an anti- 
body to the a~ cytoplasmic domain (Figure 2, lanes 2 and 
3). Positive identification of these two bands as as and 
~1 was provided by immunodepleting a biotinylated SCG 
extract via three rounds of immunodepletion with the anti- 
a~ cytoplasmic domain antibody (Figure 2, lanes 2, 4, and 
5) and then immunoprecipitating with Ralph 3-2 (lane 6) 
or with an antibody to the ~ subunit (lane 7). The anti-a~ 
cytoplasmic domain antibody depleted the extract of al- 
most all of the Ralph 3-2 antigen and the 128 kDa band 
coimmunoprecipitated by the anti-~l antibody, but did not 
deplete the extract of any of the other integrin bands immu- 
noprecipitated with e anti-~ antibody. The converse of 
this experiment, immunodepletion with Ralph 3-2 followed 
by immunoprecipitation with the anti-a~ or anti-I~ antibody 
(lanes 3 and 8-11), gave similar results. Some anti-a~ 
cytoplasmic domain immunoreactivity was not removed 
with Ralph 3-2 immunodepletion, which mayreflect either 
partial inactivation of the Ralph 3-2 epitope by biotinylation 
or the lack of the Ralph 3-2 epitope on some of the a3 
expressed on sympathetic neurons. Likewise, a very small 
amount of the a3 band is immunoprecipitated by the Ralph 
3-2 antibody after anti-a~ cytoplasmic domain immunode- 
pletion, but is seen only with long exposure times. This 
may represent expression ofa small amount of the alterna- 
tively spliced B form of the a3 cytoplasmic domain (Tamura 
et al., 1991). Similar results were obtained for Ralph 3-1 
and a non-function-blocking anti-a3 MAb, Ralph 3-3 (data 
not shown). Thus, Ralph 3-1, Ralph 3-2, and Ralph 3-3 
specifically recognize the integrin a3~. 
As shown in Figure 1 and Figure 3, Ralph 3-1 and Ralph 
3-2 inhibit neurite outgrowth by sympathetic neurons on 
TSP1 to 22% + 3.2% and 33°/0 + 5.4% of normal, re- 
spectively. Neither antibody detectably perturbed out- 
growth on Col IV or LN-1, demonstrating specificity. As
an antibody control, a function-blocking MAb to the rat 
integrin (~ subunit, 3A3, was shown to have no inhibitory 
effect on neurite outgrowth on TSP1. This same antibody 
strongly inhibits neurite outgrowth on Col IV to 8.4% + 
2.3°/0 of control, as has been seen by others (Lein et al., 
1991). As another control, a third anti-a3 MAb identified 
in our screen, Ralph 3-3, did not inhibit neurite outgrowth. 
Since a3 is only known to associate with the integrin ~ 
subunit, and the anti-13~ cytoplasmic domain antibody com- 
pletely depletes a3 from a sympathetic neuron extract 
(data not shown), the results with the anti-I~ and anti-a3 
MAbs implicate integrin a3131 as a novel TSP1 receptor. 
Sympathetic Neurlte Outgrowth 
on a TSP1 Fragment 
Our data, in agreement with those of Osterhout et al. 
(1992), show that outgrowth of sympathetic neurons on 
TSP1 can be blocked by a MAb that recognizes the proper- 
din-like repeats of TSP1 (see Figure 1B). This suggests 
that the integrin a~61 heterodimer recognizes the proper- 
din-like type 1 repeats or a nearby region. To test this 
possibility in a functional assay, a TSP1 chymotrypsin frag- 
ment (50/70 kDa) containing the procollagen-like domain, 
the TSP type 1 repeats, and a portion f the TSP type 2 
repeats (Prater et al., 1991) was tested for its ability to 
support SCG neurite outgrowth. This fragment supported 
neurite outgrowth in a dose-dependent manner (Figure 
4A). Outgrowth on the fragment was completely inhibited 
by the antibody to the 131 integrin subunit (Figure 4B). This 
result differs from whole TSP1, where neurite outgrowth is 
inhibited to only 27%. It suggests that either a non-I~l-Class 
integrin receptor or a I~l-class integrin receptor resistant 
to this antibody is present on SCG neurons and recognizes 
a different domain of TSP1. As with TSP1, anti-a3 MAbs 
Ralph 3-1 and Ralph 3-2 were found to inhibit neurite out- 
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Figure 3. Antibody Inhibition of Sympathetic 
Neurite Outgrowth 
Neurons were grown on TSP1 (A, C, and E) or 
Col IV (B, D, and F) for 16 hr in the presence 
of either no antibody (A and B), 50 p.g/ml anti-a3 
MAb Ralph 3-2 (C and D), or 50 p.g/ml anti-~zl 
MAb 3A3 (E and F). Ceils were fixed and photo- 
graphed under phase optics. Bar, 100 p.m. 
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Figure 4. Neurite Outgrowth of Sympathetic Neurons on TSP1 Frag- 
ment 
(A) Neurite outgrowth on increasing concentrations of TSP1 50•70 kDa 
fragment. 
(B) Inhibition of neurite outgrowth on 25 p.g/ml TSP1 50•70 kDa frag- 
growth on this fragment to 20%, whereas the control MAb 
against al had no effect (Figure 4B). This suggests that 
a site for integrin a31~1 interaction is located within this 
central region of TSP1. 
Immunocytochemical Distribution of (~3~1 
on Sympathetic Neurons 
To examine the distribution of ~3 on neurons, cells from 
dissociated neonatal  SCGs were cultured for 16-20 hr to 
al low extension of neurites. The cells were double labeled 
with the anti-or3 MAb Ralph 3-2, and an antibody to the 
neuron-specific marker, neurofi lament 150 kDa subunit. 
As can be seen in Figure 5, both the neurofi lament-posit ive 
neurons and the neurofi lament-negative nonneuronal 
cells expressed a3 as visualized with the Ralph 3-2 anti- 
body. Anti-a3 imm unoreactivity was intense throughout he 
neurites and was particularly strong in growth cones. 
Staining was seen in the growth cone fi lopodia, where 
ment with MAbs against ~ (Ha2/11), ct3 (Ralph 3-1 or Ralph 3-2), or 
al (3A3). Outgrowth was normalized to that seen with no antibody 
present (N). Results are mean _+ SEM; asterisk, statistically significant 
to p < .001. 
Integrin ~3131 Is a Thrombospondin-1 Receptor 
337 
Figure 5. Cellular Localization of ~3 
(A) and (B) are pictures of the same field as in (C) and (D). Sympathetic neurons were double immunostained with anti-neurofilament a d either 
Ralph 3-2 (A and B) or mouse IgG (C and D). Neurofilament (A and C) was visualized with Texas red. Ralph 3-2 (B) and mouse IgG (D) were 
visualized with fluorescein isothiocyanate (FITC). Bar, 50 p.m. 
neurofilament staining was absent, as well as in the numer- 
ous small filopodial spikes seen along the length of the 
neurite. To rule out the possibility that neuronal ~z3 expres- 
sion was induced by conditions of cell culture, mechani- 
cally dissociated sympathetic neurons were stained after 
allowing them to attach to a polyornithine-coated substrate 
for I hr. Under these conditions, 81% _ 12% of the neu- 
rons expressed detectable levels of Q3, with the level of 
expression varying greatly (data not shown). 
To confirm the expression of e~ on sympathetic neurons 
in vivo, whole SCGs were sectioned and stained with anti- 
a3 MAb Ralph 3-2, anti-neurofilament antibody, and an 
anti-TSP1 polyclonal antibody. As seen in Figure 6B, the 
anti-or3 antibody stained the borders of cells within the gan- 
glion, as well as axons extending within the outer sheath. 
Because of the high level of expression of ~z3 within the 
ganglion, individual axons within the ganglion that ex- 
pressed c¢3 could not be resolved. However, in some in- 
stances strong expression of as could be seen to colocalize 
with neurofilament staining (Figures 6A and 6B, arrows). 
Strong TSP staining was found in the outer sheath as well 
and colocalized with the axons expresssing a3 (Figure 6C). 
Thus, the in vitro and in vivo localization patterns of a3~1 
are consistent with its playing a role in axon outgrowth. 
~131 Binding Assay 
To demonstrate a direct ligand-receptor interaction be- 
tween the integrin heterodimer c¢3~1 and TSP1, a binding 
assay was developed using immunopurified a~6~ and puri- 
fied TSP1. Because of the difficulty of getting a sufficient 
amount of integrin a~6~ from sympathetic neurons, RuGli 
cells were used as a source of rat ~zsl~l integrin. RuGli cells 
were surface biotinylated and then extracted in octylgluco- 
side-containing buffer. The as~ integrin was immunopuri- 
fled from this extract with an antibody to the a~ cyto- 
plasmic domain coupled to protein A-Sepharose. The 
integrin was recovered under nondenaturing conditions 
by elution with the synthetic ct~ cytoplasmic domain pep- 
tide. As shown in Figure 7, the purified receptor contained 
two major biotinylated proteins of 130 and 112 kDa (lane 
1) that, when reduced, migrate at 116 and 121 kDa, re- 
spectively (data not shown). These same subunits were 
immunoprecipitated from the purified receptor with an an- 
tibody to the ~ cytoplasmic domain (lane 2). An antibody 
to the (~s subunit, another possible TSP1 receptor subunit 
(Yabkowitz et al., 1993), did not immunoprecipitate any 
bands from the immunopurified a3131 preparation (lane 4), 
but did immunoprecipitate a5131 from a RuGli cell extract 
(lane 5). 
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Figure 6. Localization of (z3 and TSP1 in the SCG 
Cryostat sections of a neonatal SCG were immunostained with anti-neurofilament antibody (A), anti-a3 MAb Ralph 3-2 (B), polyclonal nti-TSP1 
antibody (C), or control mouse IgG (D). (A) and (B) are pictures of the same field that has been double labeled. (C) and (D) are from nearby sections. 
Neurofilament and TSP1 were visualized by Texas red immunofluorescence. Anti-(z3 MAb Ralph 3-2 and mouse IgG were visualized by FITC 
immunofluorescence. Bar, 50 ~m. 
Purified (~3J~1 was tested for binding to substrates coated 
with ECM proteins in conditions similar to those used in 
neurite outgrowth assays. In the presence of 1 mM Ca 2. 
and 1 mM Mg 2., the immunopurified a31~ was found to 
bind to its reported ligand, LN-1 (Gehlsen et al., 1988, 
1989; Elices et al., 1991), but not to vitronectin or oval- 
bumin (Figure 8A). Figure 8A also shows that a3~ bound 
TSP1 with approximately the same efficiency as LN-I. 
Similar binding can be demonstrated with nonbiotinylated 
(~31~ detected with an antibody to the ~ cytoplasmic do- 
main, although with a much reduced signal to noise ratio 
(data not shown). The comparative efficacy of binding to 
TSP1 and LN-1 was found to vary with the batch of TSP1 
(166%-72% range). The binding efficiencies of different 
batches of TSP1 correlated with the ability to support neu- 
rite outgrowth and probably reflect the lability of an essen- 
tial binding site in this protein. 
Integrin interactions with ligands typically depend on 
divalent cations (Elices et al., 1991). As shown in Figure 
8B, binding of integrin (x31~ to TSP1 or LN-1 occurred in 
1 mM Ca 2+, 1 mM Mg 2., or 1 mM Mn 2+, but not in the 
presence of EDTA. The dependence on Ca 2+ showed sub- 
strate dependence, with binding to LN-1 being slightly 
greater at 0.1 mM than at 1 mM, while binding to TSP1 
was much reduced at 0.1 mM Ca 2+. 
As confirmation of the specificity of this interaction be- 
tween O,3~ 1 and TSP1, both function-inhibiting anti-(~3 
MAbs, Ralph 3-1 and Ralph 3-2, but not control antibodies, 
were found to decrease significantly the binding of the 
purified integrin to both LN-1 and TSP1 (Figure 8C). The 
anti-TSP1 MAb against the type 1 repeats, A 4.1 (Prater 
et al., 1991), also inhibited binding of purified integrin to 
TSP1 but not LN-1. This supports the cellular assays that 
localized the binding site to the region of the type 1 repeats. 
As further confirmation of specificity, the bound integrin 
was eluted off the substrate with SDS and EDTA after 
binding and analyzed by SDS-PAGE. The 130 kDa a3 
band and the faint 112 kDa I~1 band were eluted from LN-1- 
and TSPl-coated substrates, but not from a bovine serum 
albumin (BSA)-coated substrate (see Figure 7B). a313~ 
binding to fibronectin, but not laminin and collagen, is re- 
ported to be inhibited by a peptide containing the RGD 
sequence of fibronectin (Elices et al., 1991). However, no 
RGD peptide sequence is present in the type 1 repeats 
of TSP1, and binding of ~sl~ to TSP1 was insensitive to 
the GRGDSP peptide at concentrations up to 1 mg/ml (1.7 
raM; Figure 8C). 
Discussion 
Results in this paper show that the integrin a3131 is ex- 
pressed on the axons and growth cones of sympathetic 
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Figure 7. Immunopurified ~3P~ and Recovery from Coated Substrates 
(A) Gel analysis of immunopurified ~p,. Biotinylated ~z~pl was immuno- 
purified from RuGli cells and analyzed by SDS-PAGE on a 6% gel 
under nonreducing conditions (lane 1). Arrows indicate the ~z~ and p, 
bands. This purified ~z3 extract was subjected to immunoprecipitation 
by the anti-(~ cytoplasmic domain antibody, either without (lane 2) or 
with (lane 3) competing I~, cytoplasmic domain peptide, or by an anti- 
body to the ~5 cytoplasmic domain (lane 4). Lane 5 shows an immu- 
noprecipitation from RuGli cells with the anti-as cytoplasmic domain 
antibody. 
(B) Recovery of ~p~ bound to substrates. ~31~1 bound to substrate in 
a binding assay was eluted with 10 mM EDTA and 1% SDS. Material 
eluted from LN-1 (LN), TSP1 (TSP), or bovine serum albumin (BSA) 
was analyzed by SDS-PAGE on a nonreducing 6% gel. Positions of 
Q3 and faint ~ bands are indicated by arrows. 
neurons. On these cells it functions as a major receptor 
for TSP1 and recognizes a fragment of TSP1 containing 
the properdin-l ike or type 1 repeats. The interactions of 
Q3131 have been documented in cells using function- 
blocking MAbs to cz3 and 13~ and in receptor- l igand binding 
assays using the purified integrin. 
Four integrin-subunit specific MAbs have been used to 
analyze the role of integrins in sympathetic neurite out- 
growth on purified substrates of LN-1, Col IV, or TSPI .  
The importance of I~-class integrins was demonstrated 
with an anti-I~l MAb that inhibited outgrowth on all three 
of these substrates, having the greatest effect on Col IV 
( -92% inhibition), a large effect on TSP1 ( -73% inhibi- 
tion), and only 50% inhibition on LN-I .  It has, however, 
been reported that an anti-I~l polyclonal serum inhibits 
92% of neurite outgrowth on LN-1 (Lein et al., 1991), which 
we confirmed with several anti-I~ polyclonal antibodies 
(data not shown). Since the anti-I~ MAb completely inhibits 
outgrowth on the TSP1 50/70 kDa fragment and immuno- 
precipitates the same four ~z bands as the anti-I~l cyto- 
plasmic domain antibody (data not shown), this discrep- 
ancy between the MAb and polyclonal ant ibody effects on 
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Figure 8. Characterization of e3131 Binding 
(A) Qs131 was tested for binding to LN-1 (LN), TSP1 (TSP), vitronectin 
(VN), or ovalbumin (OA). Results from different experiments were nor- 
malized to binding on LN-1. 
(B) a3pl binding to LN-t (open bars) and TSP1 (closed bars) was done 
in the presence of either 10 mM EDTA (E), 0.1 mM Ca =* (LCa), tmM 
Ca 2., 1 mM Mg 2+, or I mM Mn 2.. Data from different experiments were 
combined by normalizing the data on both substrates to binding in 
the presence of 1 mM Ca 2.. 
(C) Inhibition of ~z~ binding by MAbs and RGD peptide. Immunopuri- 
fled a31~l was preincubated for 1 hr with either no antibody (N), Ralph 
3-1 (3-1), Ralph 3-2 (3-2), Ralph 3-3 (3-3), mouse IgG (I), or 1 mg/ml 
GRGDSP peptide (R) before addition to substrates coated with LN-1 
(open bars) or TSP1 (closed bars). Some substrates were pretreated 
with anti-TSP MAb (T) for 1 hr before addition of ~z31~,. Results are 
normalized to binding in the absence of antibody (N). Results are 
mean ± SEM; asterisk, statistically significant to p < .001 ; n.d., not 
done. 
outgrowth on LN-1 may reflect an inability of the MAb to 
inhibit all integrin heterodimers completely. Because Q3131 
is a receptor for the 50/70 kDa fragment and the anti-I~l 
MAb completely inhibits outgrowth on this fragment, it is 
l ikely that the anti-I~l MAb completely inhibits integrin cz3131 
function in our assays. Comparison of the inhibition with 
the anti-I~ MAb on whole TSP1 ( -73%)  versus the 501 
70 kDa fragment (100%) also suggests that SCG neurons 
can interact with a site outside of the 50/70 kDa fragment, 
and that this interaction is insensitive to this MAb. Results 
with the m- and a3-specific MAbs show that a3131 is a TSP1 
receptor and that, as reported by others (Lei net  al., 1991), 
m13~ is a Col IV receptor on these neurons. However, the 
same experiments also show that neither m13~ nor ~31~1 
functions as a major functional receptor for LN-1 on these 
cells. 
In the purified receptor binding assay, we found that 
purified a313~ bound to both its previously described ligand, 
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LN-1, and to TSPI. Binding to both substrates was depen- 
dent on the presence of divalent cations, with similar bind- 
ing in the presence of Ca 2+, Mg 2÷, or Mn 2+. This binding 
was specific since binding was not seen to vitronectin and 
ovalbumin, two proteins that are not ligands for a31~1. More- 
over, binding was inhibited by the same anti-co3 MAbs that 
inhibited neurite outgrowth on TSP1 but not by a non- 
function-blocking anti-cz3 MAb. Binding was also inhibited 
by an anti-TSP1 MAb that recognizes the region con- 
taining the type 1 repeats, which have been shown to in- 
hibit outgrowth of sympathetic neurons on TSP1 (Oster- 
hout et al., 1992). Thus, we demonstrate that cz31~ can 
bind directly to TSP1 in a manner similar to its binding in 
a cellular context. Because the anti-a3 antibodies inhibit 
binding to LN-1 and TSP1, binding to both substrates ap- 
pears to be mediated by a single binding site or nearby 
binding sites on ~z31~. Binding was also found to be insensi- 
tive to a peptide containing the RGD sequence that has 
been shown by others to inhibit he binding of cz3~ to fibre- 
nectin (Elices et al., 1991). This is consistent with evidence 
presented here demonstrating that ~zs~ interacts with the 
type 1 repeats of TSP1, which lack an RGD sequence. 
These results add TSP1 to the increasing list of known 
ligands for the integrin ~3~. To date, ~z~ has been de- 
scribed as a receptor for several laminin isoforms (EHS- 
laminin [LN-1], merosin [LN-2], and kalinin/epiligrin [LN-5/ 
6]), collagen, fibronectin, entactin, bacteria-derived in- 
vasin, and possibly the integrin c¢2~ (Wayner and Carter, 
1987; Elices et al., 1991; Tomaselli et al., 1993; Carter et 
al., 1991; Weitzman et al., 1993; Delwel et al., 1994; Ded- 
har et al., 1992; Isberg and Leong, 1990; Symington et 
al., 1993). Some biochemical evidence has also sug- 
gested that ~1~1 heterodimers may bind to each other in 
a homophilic manner (Sriramarao et al., 1993). In neurons 
that express ~,  however, ~1~1 does not appear to play 
a major role in neurite outgrowth on most of these sub- 
strates. Antibodies to ~1~ can inhibit the interaction of a 
neuronal cell line with LN-1, but only after ¢x~l~, another 
LN-1 receptor, has been blocked (Tomaselli et al., 1990). 
With sensory neurons, outgrowth on LN-1 is marginally 
affected by antibodies to ~,  although outgrowth on LN-2 
(merosin) is inhibited by -50% (Tomaselli et al., 1993). 
Our data show that on sympathetic neurons ~1~ does not 
play an important role in mediating neurite outgrowth on 
LN-1 or Col IV. In addition, we have found no effect of our 
antibodies on outgrowth on LN-5 (kalinin) or fibronectin 
(data not shown). The strong in hibitory effects of the anti-~3 
antibodies on neurite outgrowth on TSP1 suggest that on 
neuronal cells the most important interaction of ~31~ may 
be with TSP isoforms rather than other ligands. 
Since c¢~ is expressed in most cultured cell lines and 
in some primary cells, it is somewhat surprising that ~z~l~ 
has not been reported to be a TSP1 receptor. In fact, inte- 
grins ~z41~ and ~zsl~, but not ~1,  have been reported to 
be TSP1 receptors in activated T cells (Yabkowitz et al., 
1993), despite the expression of ~1~ in these cells and 
its function in T cell attachment o epiligrin (Wayner et al., 
1993). This suggests that the functional specificity of ct~l~ 
may be cell type dependent. Precedent for such cell type 
dependence has been found with the integrin ~2~1, which 
functions as a collagen receptor in some cells and as a 
collagen and laminin receptor in others (Elices and 
Hemler, 1989; Kirchhofer et al., 1990; Chan and Hemler, 
1993). This may also explain why neuronal c¢31~1 does not 
appear to play a major role in interactions with previously 
identified a3~1 ligands found with nonneuronal cells. Cell 
type differences might include alternative splice forms, 
alternative posttranslational modifications, or differences 
in membrane or cytoskeletal composition. Alternatively, 
the anti-~3 MAbs used in other studies may not inhibit 
binding to TSPI. Although the two function-blocking anti- 
bodies found here inhibit binding of a3131 to both TSP1 and 
LN-1, we have found a MAb that inhibits binding of a31~1 
to LN-1 but not TSP1 (unpublished ata). A third possibility 
is that the primary function of ~z~6~ is not in cell attachment, 
which most studies measure, but in other adhesive interac- 
tions such as neurite outgrowth or cell spreading. 
Integrin a313~ recognizes multiple isoforms of its ECM 
ligands. For example, a313~ appears to recognize Col I as 
well as Col IV and Col VI (Wayner and Carter, 1987; Gehl- 
sen et al., 1989; Elices et al., 1991) and also appears 
to recognize LN-1, LN-2 (merosin), and LN-5/6 (kalinin/ 
epiligrin) (Wayner and Carter, 1987; Tomaselli et al., 1993; 
Carter et al., 1991; Weitzman et al., 1993; Delwel et al., 
1994). This suggests the possibility that a31~ may be a 
receptor for other isoforms of TSP. The domains of TSP1 
found in the 50•70 kDa fragment, which we have identified 
as containing an ~3131-binding site, are present in TSP2 
and show an - 60% sequence identity with those in TSPI. 
This region is not present in TSP3, TSP4, or cartilage 
oligomeric protein, but is present in the TSP-like protein 
F-spondin, which is expressed in the ventral spinal cord 
(Klar et al., 1992). Thus, we hypothesize that TSP2 and 
possibly F-spondin are candidates as additional ligands 
for ~31~. 
The expression of ~ deduced from immunofluorescent 
staining supports the hypothesis that this ligand-receptor 
interaction may play an important role in neural develop- 
ment. cz3 is expressed on the surface of growth cones and 
their filopodial extensions and is found on sympathetic 
axons in vivo. Immunofluorescent staining with a poly- 
clonal antibody raised against TSP1 reveals that TSP is 
concentrated in the regions through which sympathetic 
axons expressing a3 travel. TSP1 is also expressed by 
endothelial cells of blood vessels, a target of sympathetic 
axons. Thus, the expression of these molecules is appro- 
priate for roles in both axon extension and target interac- 
tions. Interestingly, although very little expression of c~3 is 
seen in neuronal tissue of the neonatal rat brain, intense 
staining was found in the external granule cell layer (data 
not shown). Since antibodies to TSP isoforms inhibit gran- 
ule cell migration (O'Shea et al., 1990), cz31~ is a candidate 
to function as a TSP receptor in those neurons. Because 
TSP1 is not expressed in the cerebellum, this would re- 
quire that ~z31~ recognize another TSP isoform, possibly 
TSP2, which is appropriately expressed (Iruela-Arispe et 
al., 1993). Thus, 0f,3~1 could serve as a receptor on other 
types of neurons for TSP isoforms and play a role in other 
developmental events for which TSP isoforms are thought 
to be important. The importance, in vivo, of c¢3~ in mediat- 
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ing interact ions of  neurons  with TSP1 and o ther  TSP  iso- 
forms requ i res  fur ther  study. 
Experimental Procedures 
Mutedaio 
BSA was RIA grade fraction V from Sigma Chemical Company (St. 
Louis, MO). Synthetic peptides of the integrin subunit cytoplasmic 
domains of chick ¢¢3 (CYEAKGQKAEMRIQPSETERLIDDY), human p, 
(CDTGENPIYKSAVTTVVNPKYEGK), and human (z5 (CYGTAMEKAQ- 
LKPPATSDA) were synthesized by Dr. Chris Turck at the Howard 
Hughes Medical Institute, University of California, San Francisco. The 
GRGDSP peptide was purchased from GIBCO-BRL (Grand Island, 
NY). Hank's balanced saline solution (BSS), phosphate-buffered saline 
(PBS), Ca 2+- and Mg2+-frse PBS (CMF-PBS), fetal bovine serum (FBS), 
penicillin/streptomycin, L-15 medium, and insulin were from the UCSF 
Cell Culture Facility. DME and RPM I media were purchased from Medi- 
atech (Hemdon, VA). Nutddoma-SP was purchased from Boehringer 
Mannheim (Indianapolis, IN). Nerve growth factor (NGF) was prepared 
from rat submaxillary glands purchased from Pal Freez Siologicals 
(Rogers, AR) as described by Mobiey et al. (1976). A protease inhibitor 
cocktail, CLAP, was prepared as a 1000x stock with chymostatin, 
leupeptin, antipein, and pepstatin, each at 7 mg/ml in dimethylsulfox- 
ide. Except where indicated, chemicals were purchased from Sigma. 
Sub. rates  
Human plateiet TSP was purified as described by Dixit et al. (1984). 
The 50/70 kDa fragment of human platelet TSP was generated by 
limited digestion of TSP with chymotrypsin as described by Prater et 
al. (1991), with the following modifications. The chymotryptic digest 
of purified platalet TSP was diluted 1:4 to lower the salt concentration 
to <50 mM. The digest was then loaded on a hepadn-Sepharose 
column equilibrated with 20 mM Tris-CI (pH 7.4). The 50/70 kDa frag- 
ment was eluted with a salt gradient at -0.1 M NaCI. Gel analysis of 
this fragment by SDS-PAGE showed no contaminating bands. LN-1 
(¢¢lP~y~) was prepared from the Engelbreth Holm Swarm tumor as de- 
sCribed by Timpl et al. (1979). Human Col IV was purchased from Fluka 
Biochemika (Buchs, Switzerland). Bovine vitronectin was purchased 
from Calbiochem (San Diego, CA). An extracellular recombinant frag- 
ment of chicken N-cadherin expressed in COS cells will be described 
elsewhere (R. M. K., unpublished data). For neurite outgrowth assays 
and receptor binding assays, substrates were coated on 96-well Lin- 
bro Titertek dishes from Flow Laboratories (McLean, VA). TSP and 
N-cadherin were diluted in Hank's BSS for coating. All other substrates 
were diluted in CMF-PBS. Substrate (75 pl per well) was incubated 
on the 96-wall dishes overnight at 4°C, then blocked with 1% BSA in 
PBS for 1 hr at room temperature. 
Cell Culture 
RuGli cells (from Dr. Randy Kramer, UCSF) were grown in DME with 
10% FBS and 100 Ulml penicillin/streptomycin. Cells were passaged 
with CMF-PBS containing 10 mM EDTA. 
SCGs were dissected from Sprague-Dawiey neonatal (P0) rat pups 
purchased from Bantin and Kingman (Fremont, CA). SCGs were disso- 
ciated by manually removing the outer sheath and digested for 1 hr 
in 1 mg/ml cellagenase/dispase (UCSF Cell Culture Facility) in CMF- 
PBS. Digested SCGs were washed in CMF-PBS and triturated to dis- 
socials the cells. After two washes in in CMF-PSS, the cells were 
resuspended in serum-free 1_-15 complete medium as described by 
Hawrot and Patterson (1979), except that the N1 serum-free additives 
of Bottanstein et al. (1980) were substituted for rat serum. NGF was 
added to a final concentration of 100 ng/ml, glutamine to a concentra- 
tion of 2 mM, and BSA to a final concentration of 1 mg/ml. Cells were 
grown in a 5% CO2 atmosphere at 37°C. 
Hybridoma cells were grown in DME supplemented with 10O/o FBS 
and 100 Ulml penicillin/streptomycin. For IgG purification from super- 
natants, hybridomas were grown in serum-free medium composed of 
1:1 DME:RPMI with 1% Nutddoma-SP and 100 Ulml penicillin/strepto- 
mycin. 
Antibodies 
The anti-~ cytoplasmic domain serum, anti-Q~ cytoplasmic domain 
serum, and anti-ct~ cytoplasmic domain serum have been described 
previously (Tomasalli et al., 1988; de Curtis et al., 1991). These anti- 
sara were affinity purified on cytoplasmic peptides coupled to thiopro- 
pyI-Sepharose (Pharrnacia, Piscataway, NJ) via their amino-terminal 
cysteine residue. Antibodies were eluted with 0.1 M glycine-CI (pH 
2.3) and dialyzed against CMF-PBS. The hamster anti-I~l MAb, Ha2/ 
11, has been described previously (Mendrick and Kelly, 1993) and 
was purified from superoatants of cells cultured in protein-free medium 
(Ultradoma PF, Whittaker Bioproducts, Inc., Walken/ille, MD) by am- 
monium sulfate precipitation and dialysis against PBS. The anti-TSP1 
MAb, A 4.1, has been described previously (Prater et al., 1991) and 
was purified from hybridoma supernatant on a column with goat anti- 
mouse IgM (Zymed, South San Francisco, CA) covalently coupled to 
protein A-Sepharose (Pharmacia). The anti-TSP1 polyclonal antibody 
used for immunofluorescent s aining, named Carol, was raised against 
platelet TSP, IgG purified on protein A-sepharose, and adsorbed 
against flbdnogen. It is specific for TSP1 by immunobiot and enzyme- 
linked immunosorbent assay (ELISA). IgG of the anti-a1 MAb, 3A3 
(Turner st al., 1989), was purified from escites on MAC protein G discs 
(Amicon, Beverly, MA). Anti-bovine 150 kDa neurofilament subunit 
antibodies were purchased from Cbemicon International (Temeoula, CA). 
Generation of Function-Blocking Anti-a3 MAbs 
Immunopurified ¢¢~81 (3.5 p.g; prepared as described below, but without 
biotinylation) was mixed with RIBI adjuvant (RIBI Immunochemical 
Research, Hamilton, MT) and injected into the hind footpads of 
BALB/c mice (Simonsen Laboratories, Gilroy, CA) previously anssthe- 
tizod with avertin. The mice were boosted every 4-6 days, twice with 
10 p.g of immunopurified e31~1 in adjuvant, and once with 5 × 10 s live 
RuGli cells. The mice were boosted again with immunopurified (xs~, 
in adjuvant, 4 days before fusion. 
The monoclonal fusion was done according to standard procedures 
(Hadow and Lane, 1988). Briefly, lymph nodes were removed, mechan- 
ically dissociated, and washed with medium. They were then fused 
with an equal number of SP2/0 myeloma cells with 0.5 ml of polyethyl- 
ene glycol and 10 pl of 2.25 M CaCI=. After washing with medium, 
cells were plated at limiting dilution in wells prsplated with 0.5 x 10 s 
to 3 x 105 peritoneal washout feeder cells per milliter (prepared as 
described in Hariow and Lane, 1988). 
Resulting hybridoma supernatants were first screened by ELISA on 
live RuGli cells. Positive clones were grown in 1% Nutridoma and 
screened by immunoprecipitation of biotinylated RuGli cell extracts 
and SDS-PAGE. A total of 32 MAbs were obtained that immunoprecipi- 
tated only the eal~ heterodimer. These were subcloned and grown in 
1% Nutddoma. IgG was purified from Nutridoma supernatants on a 
protein G-Sepharose 4 Fast Flow (Pharmacia) column and tested in 
function-blocking assays. Antibodies were tested at 50 p.g/ml, and 2 
MAbs (Ralph 3-1 and Ralph 3-2) were found to inhibit neurite outgrowth 
on TSPI. 
Neurlte Outgrowth Assays 
Dissociated sympathetic neurons, suspended in serum-free L-15 com- 
plete medium, were diluted to 2000-6000 cells/ml (see Celt Culture). 
Antibodies were diluted into serum-free medium at twice the desired 
final concentration. Each of the MAbs was normally used at a 50 p~g/ 
ml final concentration, except for Ha2/11, which was used at 100 I~g/ 
ml. An equal volume of cell suspension was added to the antibody 
aliquots and allowed to absorb to the ceils for 30 rain at room tempera- 
ture. After preadsorption, the cells were resuspended, and 100 p.I was 
centrifuged onto each well of a substrata-coated 96-well dish at 500 
x g for 10 min and grown in a 5O/o CO2 atmosphere for 15-18 hr. 
Cells were fixed by adding 200 p.I per well of 10% formalin, 50/o sucrose 
in PBS. 
For quantitation of neudte outgrowth, the number of neurites with 
lengths greater than or equal to five cell body diameters in a unit area 
was counted. Only neurites originating within a unit area were counted. 
Care was taken to count similar areas in different wells, since neurite 
outgrowth can vary within a well (e.g., center versus edge). Although 
quantitation of the number of neurites per unit area and the percentage 
of neurons with neurites gave similar results (see Figure 1), the former 
method was used for routine quantitation. Assays were done in dupli- 
cate at least three times, and results were normalized to a no-antibody 
control. Statistical analysis was done with StatView software (Abacus 
Concepts, Inc., Berkeley, CA) by ANOVA using Scheffe's F procedure. 
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Blotlnyletlon of Cell Surface Proteins 
For biotinylation of RuGli cell surface proteins, cells were grown to 
confluency in 75 cm 2 tissue culture flasks. For biotinylation of sympa- 
thetic cultures, approximately ten dissociated SCGs were plated in a 
well of a 6-well Primaria dish (Becton Dickinson Labware, Franklin 
Lakes, N J) coated with 5 p.g/ml LN-1 and grown for 4 days in culture 
to allow the production of a dense axonal plexus. Biotinylation was 
performed by a modification of the procedure described by Miyake et 
al. (1991). Briefly, confluent 75 cm z tissue culture flasks of RuGli cells 
or 6-well dishes of dissociated SCG cultures were washed twice with 
warm PBS, after which 2 ml of PBS/0.1 M Na-HEPES (pH 8.0) was 
added to each flask or well with 80 p.I of 10 mg/ml sulfo-NHS-biotin 
(Pierce Chemical Company, Rockford, IL) in PBS. After rocking for 1 
hr at room temperature, cells were washed twice with PBS, removed 
from the flask or well with CMF-PBS with 10 mM EDTA, washed again 
with CMF-PBS with 10 mM EDTA, and washed once with PBS to 
remove unreacted sulfo-NHS-biotin. 
Immunopreclpitstlon from Biotinylated Extracts 
Biotinylated RuGli cells or sympathetic neurons were solubilized in 
buffer A (lO/o Triton X-100 in PBS with CLAP and 1 mM phsnylmethyl- 
sulfonyl fluoride [PMSF]) with 50 mM Tris-CI (pH 7.5). The extracts 
were spun at 10,000 x g for 15 min, and 10 p.g of antibody was 
coupled to 30 I~1 of protein A-Sepharose for each immunoprecipitation. 
Biotinylated extracts were added and incubated overnight at 4°C. The 
Sepharose was then washed five times with buffer A and once with 
PBS with 1 mM PMSF and CLAP. Sample buffer was added, and 
the samples were boiled for 5 min, then run on 6% SDS-PAGE gels 
according to standard protocols. The proteins were transferred to nitro- 
cellulose (Schleicher & Schuell, Keene, NH), which was subsequently 
blocked with 5°/0 Carnation nonfat dry milk, 30/0 BSA fraction V (Sigma), 
0.1% Tween-20 in PBS for I hr, washed three times with PBS, and 
incubated with horseradish peroxidase-streptavidin (Zymed Labora- 
tories, Inc., South San Francisco, CA) in 0.1% Tween-20/PBS for 1 
hr. The blot was washed once in Tris-buffered saline (TBS), twice in 
TBS with 1% Triton X-100, 1% SDS, 0.5% deoxycholate, and twice 
again in TBS for 5 min each. The blot was visualized with enhanced 
chemiluminescence reagent (Amersham, Buckinghamshire, England). 
Immunocytochemlstry 
Dissociated neurons were grown on 16-well glass chamber slides 
(Nunc, Naperville, IL) coated with 1 mg/ml polyornithine in CMF-PBS 
for 30 rain, followed by 10 p.g/ml Col IV for 1 hr or overnight. Cells 
were cultured for 18-20 hr, fixed with 10% formalin, 0.1% Triton X-100 
in PBS for 15 min, and stained according to standard procedures 
(Harlow and Lane, 1988). For staining whole ganglia, SCGs were dis- 
sected from neonatal rats, fixed in 4O/o paraformaldehyde for 1 hr, and 
equilibrated with 30% sucrose in PBS overnight at 4°C. SCGs were 
then frozen in liquid nitrogen and cryostat sectioned. Sections (10 p.m) 
were fixed with methanol at -200C for 10 min and stained according 
to standard procedures. Secondary antibodies were FITC-conjugated 
goat F(ab')2 anti-mouse IgG and Texas red-conjugated goat F(ab')2 
anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA). Slides 
were mounted under coverslips with FITC-Guard (Tastog, Inc., Chi- 
cago, IL). 
o4131 Immunopurlflcatlon 
To immunopurify as131, 10 mg of affinity-purified anti-a~ cytoplasmic 
domain antibody was cross-linked to 3 ml of protein A-Sepharosa 
(Pharmacia) with 20 mM dimethlypimelimidate (Pierce) in 0.2 M Na- 
borate (pH 9.0) as described by Harlow and Lane (1988) and blocked 
with 0.2 M ethanolamine (pH 8.0). Biotinylated or nonbiotinylated RuGli 
cells from four confluent flasks were extracted in buffer B (50 mM 
N-octyl-~-D-glucopyranoside, 50 mM Tris--CI [pH 7.5], 15 mM NaCI, 
1 mM PMSF, CLAP) with 1 mM CaCI2 and 1 mM MgCI2, centrifuged 
at 10,000 x g for 15 min, and incubated with CL-4B Sepharose (Phar- 
macia). The supernatant was then incubated with anti-a~-Sepharosa 
for at least 4 hr. Following six washes in buffer B, a31~, was eluted for 
1 hr with the aa, cytoplasmic domain peptide (1 mg/ml in buffer B). 
Receptor Binding Amy 
Wells were coated and blocked as described above. Receptor purified 
as described above was diluted in buffer B with 1 mM CaCI2 and 1 
mM MgCI2 at 1:10 to 1:50, respectively. The solutions were added to 
the substrata-blocked dishes and allowed to bind at room temperature 
for 2 hr. The wells were then washed five times with buffer C (25 mM 
N-octyl-I~-D-glucopyranoside, 50 mM Tris-CI [pH 7.5], 15 mM NaCI, 
1 mM PMSF, CLAP) with 1 mM CaCI2 and 1 mM MgCI2 and incubated 
with streptavidin-conjugated horseradish peroxidase (Zymed) diluted 
in the same buffer, for I hr at 40C. After washing five times more with 
buffer C with 1 mM CaCI2 and 1 mM MgCI2, binding was assayed 
by developing with 3,3',5,5'-tetramethylbenzidine r agent (Kirkegaard 
and Perry, Gaithereburg, MD) and stopping the reaction with an equal 
volume of 1 M H3PO4. Absorbance at 450 nm was read in a microtiter 
plate reader (Flow Laboratories). Results were zeroed to wells with 
no receptor added. For experiments testing different divalent cations, 
1 mM CaCI2 and 1 mM MgCI2 were replaced by the divalent cation 
tested. For experiments with antibodies added, receptor was used at 
a 1:50 dilution with antibody at 150 p.g/ml. The receptor and antibody 
were incubated at room temperature for 1 hr before the binding assay. 
Statistical analysis was as described for the neurite outgrowth assay. 
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